Lazard Upgrades Thoratec (THOR) to Hold
More News related to THOR
- Standard & Poor's Announces Changes to U.S. Indices
- Thoratec Presentation at Piper Jaffary Conference to be Webcast
- Stifel Nicolaus Initiates Coverage on Thoratec (THOR) with a Hold
- Canaccord Adams Downgrades AtriCure (ATRC) to Hold
- Canaccord Adams Reiterates a 'Buy' on Thoratec (THOR)
More News related to Upgrades
- BMO Upgrades Spectrum Brands (SPC) to Market Perform
- Maxim Upgrades Palomar Medical (PMTI) to Buy
- RBC Capital Upgrades DSP Group (DSPG) to Sector Perform
- UBS Upgrades Morgans Hotel Group (MHGC) to Buy
- Janney Montgomery Scott Upgrades Wright Express Corp (WXS) to Buy.
Lazard Capital upgrades Thoratec (Nasdaq: THOR) from Sell to Hold.
Thoratec Corporation manufactures circulatory support products for use by patients with heart failure.
Related Categories
UpgradesStocks Mentioned
+0.52Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
